pifithrin has been researched along with Deafness in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Gao, Y | 1 |
| Zhang, R | 1 |
| Sun, F | 1 |
| Cheng, C | 1 |
| Qian, F | 1 |
| Duan, X | 1 |
| Wei, G | 1 |
| Sun, C | 1 |
| Pang, X | 1 |
| Chen, P | 1 |
| Chai, R | 1 |
| Yang, T | 1 |
| Wu, H | 1 |
| Liu, D | 1 |
1 other study available for pifithrin and Deafness
| Article | Year |
|---|---|
THOC1 deficiency leads to late-onset nonsyndromic hearing loss through p53-mediated hair cell apoptosis.
Topics: Animals; Apoptosis; Benzothiazoles; CRISPR-Associated Protein 9; Deafness; Disease Models, Animal; D | 2020 |